The Influence of Affect on Cognition
Hallucinogens and Psychedelics
Altered States of Awareness
The Placebo Effect
Role of Amygdala in Memory
CNS Stimulants: Psychedelic Agents
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: Apr 28, 2026

Brain Morphology of Cannabis Users With or Without Psychosis: A Pilot MRI Study
Published on: August 18, 2020
Rainer Kraehenmann1, Katrin H Preller2, Milan Scheidegger3
1Department of Psychiatry, Psychotherapy and Psychosomatics, University of Zurich and Swiss Federal Institute of Technology, Zurich, Switzerland; Department of Neuropsychopharmacology and Brain Imaging, University of Zurich and Swiss Federal Institute of Technology, Zurich, Switzerland.
Psilocybin, a psychedelic compound, reduced amygdala reactivity to negative stimuli in healthy adults. This brain change was linked to improved mood, suggesting potential therapeutic benefits for mood disorders.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: